Rocilinostat

CAS No. 1316214-52-4

Rocilinostat ( ACY-1215 )

Catalog No. M11280 CAS No. 1316214-52-4

Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM in a cell-free assay.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 55 In Stock
50MG 71 In Stock
100MG 104 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rocilinostat
  • Note
    Research use only, not for human use.
  • Brief Description
    Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM in a cell-free assay.
  • Description
    Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM in a cell-free assay. It is >10-fold more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight activity against HDAC8, minimal activity against HDAC4/5/7/9/11, Sirtuin1, and Sirtuin2. Phase 2.
  • Synonyms
    ACY-1215
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC1; HDAC2; HDAC3; HDAC6; HDAC8
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1316214-52-4
  • Formula Weight
    433.50
  • Molecular Formula
    C24H27N5O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 86 mg/mL (198.38 mM)
  • SMILES
    O=C(C1=CN=C(N(C2=CC=CC=C2)C3=CC=CC=C3)N=C1)NCCCCCCC(NO)=O
  • Chemical Name
    2-(diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Santo L, et al. Blood, 2012, 119(11), 2579-2589.
molnova catalog
related products
  • JAK/HDAC-IN-1

    JAK/HDAC-IN-1 is an effective JAK2/HDAC dual inhibitor (IC50s: 4 and 2 nM for JAK2 and HDAC). It also shows antiproliferative and proapoptotic activities in several hematological cell lines.

  • Cedryl acetate

    The fungal transformation of cedryl acetate was investigated for the first time by using Cunninghamella elegans.

  • Belinostat

    Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.